BR112023018929A2 - Formulações estáveis de indocianina verde - Google Patents

Formulações estáveis de indocianina verde

Info

Publication number
BR112023018929A2
BR112023018929A2 BR112023018929A BR112023018929A BR112023018929A2 BR 112023018929 A2 BR112023018929 A2 BR 112023018929A2 BR 112023018929 A BR112023018929 A BR 112023018929A BR 112023018929 A BR112023018929 A BR 112023018929A BR 112023018929 A2 BR112023018929 A2 BR 112023018929A2
Authority
BR
Brazil
Prior art keywords
indocyanine green
stable
formulations
green formulations
compositions
Prior art date
Application number
BR112023018929A
Other languages
English (en)
Portuguese (pt)
Inventor
Babak Sayah
Florian Courivaud
Marina Laurent
Nicolas Lopez
Original Assignee
Provepharm Life Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provepharm Life Solutions filed Critical Provepharm Life Solutions
Publication of BR112023018929A2 publication Critical patent/BR112023018929A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112023018929A 2021-03-17 2022-03-14 Formulações estáveis de indocianina verde BR112023018929A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21305324 2021-03-17
PCT/EP2022/056446 WO2022194734A1 (en) 2021-03-17 2022-03-14 Stable formulations of indocyanine green

Publications (1)

Publication Number Publication Date
BR112023018929A2 true BR112023018929A2 (pt) 2023-10-10

Family

ID=75302476

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023018929A BR112023018929A2 (pt) 2021-03-17 2022-03-14 Formulações estáveis de indocianina verde

Country Status (7)

Country Link
US (1) US20240156991A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308076B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024510501A (cg-RX-API-DMAC7.html)
CN (1) CN117098532A (cg-RX-API-DMAC7.html)
BR (1) BR112023018929A2 (cg-RX-API-DMAC7.html)
ES (1) ES3042376T3 (cg-RX-API-DMAC7.html)
WO (1) WO2022194734A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4308082A1 (en) * 2021-03-17 2024-01-24 Provepharm Life Solutions Stable formulations of indocyanine green

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509260A (ja) * 1993-04-20 1996-10-01 マリンクロット・メディカル・インコーポレイテッド 電圧感受性染料の安定化
FR2710060B1 (fr) 1993-09-17 1995-11-17 Rech Biolog Et Procédé de préparation de benz[e]indoles substitués de pureté élevée et leurs sels alcalins.
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
CA2635975A1 (en) * 2006-01-04 2007-07-12 Do-Coop Technologies Ltd. Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
DE102007030403A1 (de) 2007-06-29 2009-01-08 Universität Bielefeld Verfahren zur Verbesserung der Photostabilität von Fluoreszenzfarbstoffen
CN103301482B (zh) 2013-06-27 2014-12-17 深圳先进技术研究院 两亲性三嵌段聚多肽载icg胶束及其制备方法
JP6623479B2 (ja) 2015-02-08 2019-12-25 トンリ・バイオメディカル・カンパニー・リミテッド 脂質ナノ粒子及びその使用
CA3021809A1 (en) * 2015-05-11 2016-11-17 Dicronis Sagl Compositions for circulatory system visualization
DK3383436T3 (da) 2015-12-01 2023-11-20 Dishman Carbogen Amcis Ltd Forbedret fremgangsmåde til fremstilling af indocyaningrønt
US20190337896A1 (en) 2018-05-02 2019-11-07 Biophore India Pharmaceuticals Pvt. Ltd. PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
WO2020240514A1 (en) 2019-05-30 2020-12-03 Leiutis Pharmaceuticals Pvt, Ltd. Stable formulations of indocyanine green

Also Published As

Publication number Publication date
EP4308076A1 (en) 2024-01-24
EP4308076B1 (en) 2025-07-16
CN117098532A (zh) 2023-11-21
ES3042376T3 (en) 2025-11-20
JP2024510501A (ja) 2024-03-07
WO2022194734A1 (en) 2022-09-22
US20240156991A1 (en) 2024-05-16

Similar Documents

Publication Publication Date Title
MX2020007148A (es) Formulaciones.
CR7765A (es) Queso crema bajo en proteina
CL2020002252A1 (es) Formulación oftálmica.
MX2020000333A (es) Formulaciones de conjugado anticuerpo anti-egfr-farmaco.
CR8986A (es) Isoxazoles sustituidos como fungicidas
ATE556414T1 (de) Leitfähige polymerzusammensetzungen in optoelektrischen einrichtungen
CY1114712T1 (el) Υδατικες φαρμακευτικες συνθεσεις περιεχουσες συμπλοκα βορικου-πολυολης
MX2019014772A (es) Formulaciones en gel de bisfosfocinas y usos de estas.
PH12014500773A1 (en) Tooth film formulations
ECSP044981A (es) Composicion oftalmica que comprende ascomicina
UA111065C2 (uk) Композиції норибогаїну
CR20110190A (es) Agente rodenticida sinérgico
BR112021023274A2 (pt) Formulações de terlipressina
GT200400257A (es) Composicion herbicida
DE502007001593D1 (de) Regal-fachboden
UY33412A (es) Composiciones pesticidas con dionas cíclicas y de toxicidad reducida
MX2021008983A (es) Atributos de aflibercept y metodos de caracterizacion y modificacion de los mismos.
AR051415A1 (es) Composicion consumible con antioxidantes
EP3745846A4 (en) HERBAL MICROBIAL PREPARATIONS, COMPOSITIONS AND FORMULATIONS THEREOF, AND USES THEREOF
GT200900045A (es) Sales de bencimidazolilo piridilo eteres y las formulaciones del mismo
WO2014169003A3 (en) Multi-functional composition for cosmetic formulations
BR112021025317A2 (pt) Tienilhidroxiisoxazolinas e derivados das mesmas
MX2024002865A (es) Composicion que contiene cariofileno.
BR112023018942A2 (pt) Formulações estáveis de indocianina verde
PH12019502389A1 (en) Oral care compositions